Outcome of Percutaneous Patent Foramen Ovale Closure with the Premere Occluder — A Single Center Experience
Journal Title: Journal of Cardiobiology - Year 2014, Vol 2, Issue 1
Abstract
Introduction: Percutaneous closure of patent foramen ovale (PFO) has become a widely used procedure in patients with suspected paradoxical embolism. Despite being generally safe and effective, the minimally invasive intervention has been associated with several serious complications such as air embolism, cardiac perforation, device embolization, device thrombus formation and puncture site problems. Unlike the conventionally used devices originally designed for closure of atrial septum defects, the novel Premere PFO Closure System (St. Jude Medical, St. Paul, MN, USA) was exclusively designed for PFO occlusion. We therefore aimed to evaluate the safety and efficacy of the novel Premere PFO Closure System in patients with PFO and a previous transient ischemic attack (TIA) or stroke. Methods: 67 patients (mean age 47 ± 29 years) who underwent PFO closure with the novel Premere device were analyzed retrospectively. Indications for PFO closure were prior stroke (n=42), transient ischemic attack (n=20), or other related clinical events such as peripheral embolism (n=5). PFO was documented in all patients by transthoracic and transesophageal echocardiography. Procedural success was confirmed by fluoroscopy with contrast injection through the guiding catheter. Mid-term safety and efficacy was evaluated by clinical follow-up, including echocardiography (TTE/TEE) scheduled at 6 months after PFO closure. Results: Follow-up data was available in 64 patients (95.5%). Device implantation was successful in all patients without any periprocedural complications. At clinical follow-up after a median of 189 ± 135 days, one patient (1.6%) presented with device thrombus, which resolved under oral anticoagulation without further complications. Another was diagnosed with new onset of atrial fibrillation. One patient each had experienced a recurrent stroke and a transient ischemic attack. While in the former case no residual shunt could be detected, the later was likely related to device malposition. At echocardiographic follow-up, significant residual shunt was noted in 6 patients (9.4%).Conclusion: In our series we demonstrate that percutaneous PFO closure using the dedicated Premere occluder is safe and effective. Type and rate of complications are in line with other studies assessing this closure device.
Authors and Affiliations
Thomas Lüscher
Keywords
Related Articles
- EP ID EP200158
- DOI 10.13188/2332-3671.1000007
- Views 85
- Downloads 0
Changes in Glucose-6-phosphate Dehydrogenase Activity in Paroxysmal Atrial Fibrillation
Background: The antioxidant defense system has been subject to investigations in various cardiovascular diseases. The studies of its status in paroxysmal atrial fibrillation are scarce. The enzyme glucose-6-phosphate deh...
Sick Sinus Syndrome Induced by Giant Coronary Artery Aneurysm Rupture in a Patient with Constrictive Pericarditis
Multiple coronary artery aneurysms (CAA) with a giant CAA are rare. Patient with a giant CAA is at risk of thrombosis, aneurysm rupture and even sudden cardiac death. We reported a case of a 78-year-old woman having a gi...
Valsalva Retinopathy Associated with Choking and Heimlich Maneuver
Valsalva is “a particular form of retinopathy, pre-retinal and hemorrhagic in nature, secondary to a sudden increase in intrathoracic pressure”. Increasing intrathoracic pressure against a closed glottis diminishes venou...
Multistep Progression from Atypical Adenomatous Hyperplasia to Lung Adenocarcinoma: Clinico-Pathologic, Epigenetic and Genetic Aspects
Detection of small peripheral ground-glass opacity nodules has increased due to the advances in imaging modalities and the widespread use of computed tomography screening. Pathologic examination of these nodules revealed...
Association between Subclinical Hypothyroidism and Cardiovascular Mortality in Patients Suffered from Heart Failure with Preserved Ejection Fraction
Background: Subclinical hypothyroidism (SCH) is underdiagnosed in patients (pts) with heart disease, however, there has been controversy surrounding whether it is a cardiovascular risk factor or not. To determine the pro...